Exclusion Criteria
Female patients who are pregnant, breastfeeding, or lactating
boolean
Regularly scheduled plasma exchange (PE) or intravenous immunoglobulin (IVIG) treatment, or PE or IVIG treatment within 8 weeks prior to randomization
boolean
CellCept or other immunosuppressive therapy, except corticosteroids, exceeding 2 weeks total duration and within 8 weeks prior to randomization
boolean
Use of PV therapies other than those noted above, within 4 weeks prior to randomization
boolean
Use of topical corticosteroids within 2 weeks prior to randomization
boolean